#
Title
1

Vijay K Ramanan, MD, PhD, FAAN / Sharon J. Sha, MD, MS - Charting a New Course for Alzheimer’s: Adapting Clinical Practice to Evolving Patient Needs in the Era of Early Disease Detection and Modification

2

Prof. David Planchard, MD, PhD / Paolo Tarantino, MD, PhD - Scaling New Heights in Lung and Breast Cancer Care: Harnessing the Power of Antibody–Drug Conjugates in Patients With Brain Metastases

3

Neelam Goyal, MD / Gil I. Wolfe, MD, FAAN - Spotlight on Seronegative Generalized Myasthenia Gravis: From Clinical Uncertainty to Personalized Treatment

4

Charles Vega, MD, FAAFP - Optimizing MDD Management in Primary Care: Advancing Patient Outcomes Through Better Assessment and Team-Based Solutions

5

Ana M. Franceschi, MD, PhD - AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions and Support Rapid Recognition and Response in Radiology

6

James R. Kilgore, DMSc, PhD, PA-C, DFAAPA - Remembering Brain Health: Reshaping Care Models to Achieve Meaningful Impact Across the Lifespan

7

Prof. Nick Fox - Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer's Disease: Key Takeaways From AD/PD 2025 and AAN 2025

8

Jeffrey L. Neul, MD, PhD - The Changing Future for Patients With Rett Syndrome and Their Families: Early Diagnosis and New and Emerging Therapies to Reduce the Burdens of Disease

9

Michael Levy, MD, PhD - Test Your Knowledge: Are You Missing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD)?

10

James F. Howard Jr., MD - Identifying Myasthenia Gravis and Assessing Patients’ Response to Treatment to Improve Outcomes

11

Val J. Lowe, MD - Revealing the Neuropathology of Alzheimer’s Disease Through Novel Fluid and Imaging Biomarkers: Ushering in a Precision Era of Diagnosis and Treatment

12

David Cornblath, MD - Optimizing Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy: Honing Diagnostic Accuracy, Personalizing Treatment Plans